Complete Guide to Gout Lab Tests: What to Get and How to Interpret Results

If you’ve been experiencing joint pain and suspect gout might be the culprit, you’re probably wondering which tests you actually need. The diagnostic journey for gout involves more than just checking uric acid levels—understanding the full picture requires several key laboratory and imaging assessments.

This guide walks you through every test a gout patient should consider, explains what the results mean, and helps you have more productive conversations with your healthcare provider.

Why Comprehensive Testing Matters

Here’s a crucial reality many patients don’t realize: approximately 30% of people experience normal uric acid levels during an acute gout flare. This paradox occurs because inflammatory cytokines temporarily lower circulating uric acid, and increased urinary excretion during inflammation can mask elevated levels.

This is why a single uric acid test—even during a painful attack—provides incomplete information. Comprehensive testing helps you:

• Confirm the diagnosis definitively
• Assess kidney and liver function (crucial for medication safety)
• Identify comorbid conditions that affect treatment choices
• Establish baseline measurements for monitoring progress
• Detect complications early, when intervention is most effective

The Essential Lab Tests Every Gout Patient Needs

1. Serum Uric Acid (sUA)

This is the cornerstone test for gout, measuring uric acid concentration in your blood. However, timing and conditions matter significantly.

Diagnostic thresholds (per ACR guidelines):

• Men: Hyperuricemia defined as > 7.0 mg/dL (> 416 μmol/L)
• Women: Hyperuricemia defined as > 6.0 mg/dL (> 357 μmol/L)
• Uric acid crystallizes at levels > 6.8 mg/dL

Critical testing tips:

• Fast for 8-12 hours before the test (morning fasting preferred)
• Avoid the test during an acute flare (wait 2-4 weeks after symptoms resolve)
• Disclose all medications, including supplements, as some can falsely lower results
• Results should be interpreted alongside clinical symptoms and imaging findings

What it tells you: While hyperuricemia is necessary for gout, it’s not sufficient for diagnosis. Many people with elevated uric acid never develop gout. Conversely, as mentioned, some patients with active gout have normal levels during flares.

2. Serum Creatinine and Estimated GFR (eGFR)

Creatinine is a waste product filtered from blood by your kidneys. When kidney function declines, creatinine accumulates—making this test essential for assessing renal health.

Understanding the numbers:

• Normal creatinine (men): 0.7-1.3 mg/dL
• Normal creatinine (women): 0.6-1.1 mg/dL
• eGFR normal range: > 90 mL/min/1.73m²
• eGFR 30-59: Moderate kidney disease (medication adjustment often needed)
• eGFR < 30: Severe kidney disease (requires specialized management)

Why it matters for gout patients:

• Gout and kidney disease often coexist—uric acid is both a cause and consequence of renal impairment
• Most gout medications require dose adjustment or are contraindicated in kidney disease
• Creatinine helps calculate safe medication dosing
• Elevated creatinine may indicate urate nephropathy (kidney damage from uric acid)

3. Liver Function Tests (ALT, AST, Bilirubin)

Your liver metabolizes most gout medications, including allopurinol, febuxostat, and colchicine. Baseline liver testing and periodic monitoring are essential safety measures.

Key markers:

• ALT (Alanine Aminotransferase): Most specific for liver cell damage
• AST (Aspartate Aminotransferase): Elevated in liver and muscle damage
• Alkaline Phosphatase: Elevated in bile duct obstruction
• Bilirubin: Elevated in severe liver dysfunction

Clinical significance:

• Fatty liver disease affects up to 75% of gout patients
• Baseline testing before starting urate-lowering therapy is standard of care
• Allopurinol and febuxostat can cause rare but serious liver injury
• Monthly monitoring recommended during the first 3 months of urate-lowering therapy

4. Complete Blood Count (CBC)

The CBC provides information about your red blood cells, white blood cells, and platelets—offering insights into overall health and detecting hidden conditions.

What it reveals:

• Anemia: Common in patients with chronic kidney disease or inflammatory conditions
• White blood cell count: Elevated during acute inflammation or infection
• Platelets: Abnormalities may indicate underlying hematologic disorders

5. Lipid Panel

High cholesterol and gout share common underlying mechanisms involving metabolic dysfunction. A lipid panel typically includes:

• Total cholesterol: Should be < 200 mg/dL
• LDL (bad cholesterol): Should be < 100 mg/dL (lower if cardiovascular disease present)
• HDL (good cholesterol): Should be > 40 mg/dL (men), > 50 mg/dL (women)
• Triglycerides: Should be < 150 mg/dL

Clinical pearl: Studies show over 75% of gout patients have hypertriglyceridemia. Research from Jilin University First Hospital found that febuxostat, but not allopurinol, demonstrated lipid-lowering effects alongside uric acid reduction—potentially offering cardiovascular benefits.

6. Fasting Glucose and HbA1c

The connection between gout and diabetes is bidirectional—elevated uric acid increases diabetes risk, and diabetes impairs uric acid excretion.

Diagnostic thresholds:

• Fasting glucose: Normal < 100 mg/dL; Pre-diabetic 100-125 mg/dL; Diabetic ≥ 126 mg/dL
• HbA1c: Normal < 5.7%; Pre-diabetic 5.7-6.4%; Diabetic ≥ 6.5%

Clinical significance: A 9-year study of 2,690 Chinese adults found that each 1 mg/dL increase in uric acid raised type 2 diabetes risk by 17%. Patients with the highest uric acid levels had 3.3 times greater diabetes risk compared to those with the lowest levels.

7. Urine pH

Uric acid solubility in urine depends heavily on pH levels—understanding this helps optimize treatment and prevent kidney stone formation.

The science:

• Uric acid becomes more soluble as urine becomes more alkaline
• At pH 5.0: Only 15 mg/dL of uric acid stays dissolved
• At pH 7.0: Up to 200 mg/dL remains dissolved
• Target urine pH for gout patients: 6.5-7.0

How to measure:

• Urinalysis at a laboratory
• At-home pH strips (litmus paper) for daily monitoring
• Best tested on second morning urine

Clinical application: Patients with persistently acidic urine (pH < 6.0) benefit from alkalinization therapy—potassium citrate or sodium bicarbonate—to prevent uric acid kidney stones and enhance uric acid excretion.

Advanced Imaging Tests

Joint Fluid Analysis (Arthrocentesis)

Considered the gold standard for gout diagnosis, this procedure involves extracting fluid from the affected joint and examining it under polarized microscopy.

What technicians look for:

• Negatively birefringent, needle-shaped monosodium urate crystals
• WBC count typically elevated (often > 2,000/μL during acute flares)
• Neutrophil predominance during acute attacks

Important considerations:

• Most accurate when done during an acute flare
• Ideally performed before starting anti-inflammatory medications
• Requires an experienced rheumatologist or interventional radiologist
• Generally safe, though infection risk (septic arthritis) must be ruled out

Dual-Energy CT (DECT) Scan

This specialized imaging uses two different X-ray wavelengths to distinguish urate crystals from calcium—allowing visualization of uric acid deposits that don’t show on regular X-rays.

Clinical applications:

• Definitive diagnosis when joint fluid analysis is inconclusive
• Detecting uric acid deposits before clinical tophi appear
• Monitoring response to urate-lowering therapy
• Identifying crystal burden in complex cases

Advantages:

• Non-invasive
• Can image multiple joints simultaneously
• Quantitative assessment of crystal volume
• Can distinguish gout from pseudogout (calcium pyrophosphate disease)

Musculoskeletal Ultrasound

Increasingly used in rheumatology practice, ultrasound can reveal characteristic gout findings:

• Double contour sign: Urate deposition on cartilage surface
• Snowstorm appearance: Floating particles in synovial fluid
• Tophi: Visible nodules containing urate crystals
• Power Doppler: Increased blood flow indicating active inflammation

Specialized Tests to Consider

HLA-B*5801 Genetic Testing

Before starting allopurinol, particularly in patients of Asian, African, or Pacific Islander descent, genetic testing for HLA-B*5801 is strongly recommended.

Clinical significance:

• HLA-B*5801 prevalence: Up to 20% in Han Chinese, 10-15% in Koreans, 8-10% in Thai patients
• Associated with severe cutaneous adverse reactions (SCARs): Stevens-Johnson syndrome and toxic epidermal necrolysis
• Mortality rate for SJS/TEN: 20-30%
• Testing is increasingly recommended regardless of ethnicity

24-Hour Urine Uric Acid Collection

This test determines whether your gout is primarily due to overproduction or underexcretion of uric acid—crucial information for selecting appropriate urate-lowering therapy.

Collection procedure:

• Collect all urine over a 24-hour period
• Maintain a low-purine diet for 3 days before collection
• Avoid alcohol during collection period
• Normal excretion: 400-600 mg/day
• > 600-800 mg/day suggests overproduction
• < 400 mg/day suggests underexcretion

Putting It All Together: A Recommended Testing Panel

Based on ACR guidelines and clinical best practices, here’s a comprehensive initial workup:

Test	Frequency	Purpose
Serum Uric Acid	Every 3-6 months during titration; annually when stable	Monitor treatment target achievement
Creatinine / eGFR	Baseline and every 6-12 months	Assess kidney function, guide dosing
ALT / AST	Baseline, monthly for 3 months, then every 6-12 months	Monitor for hepatotoxicity
Lipid Panel	Annually	Cardiovascular risk assessment
Fasting Glucose / HbA1c	Annually	Diabetes screening
Complete Blood Count	Annually	General health monitoring
Urinalysis (pH)	As needed, especially if kidney stones suspected	Assess urine alkalization needs

Questions to Ask Your Doctor

After receiving your test results, consider asking:

1. What are my exact uric acid levels, and have I reached the target of < 6 mg/dL?
2. How is my kidney function? Does this affect my medication choices?
3. Are my liver enzymes normal? Do I need monitoring while on urate-lowering therapy?
4. Should I be screened for diabetes given my gout diagnosis?
5. Would joint imaging help establish the diagnosis or guide treatment?
6. Do I need HLA-B*5801 testing before starting allopurinol?

The Takeaway

Comprehensive testing isn’t just about confirming gout—it’s about understanding your entire metabolic health, identifying complications early, and selecting treatments that are both effective and safe for your specific situation.

Working with a rheumatologist who takes a thorough approach to gout management can make the difference between struggling with recurrent flares and achieving sustained remission. Don’t settle for a single uric acid test and a prescription—demand a complete picture of your health.

Understanding lab results is key. See our uric acid levels chart.

The flare treatment guide explains what to do when tests show elevated uric acid.